Virucidal efficacy of a novel silver-based disinfectant against SARS-CoV-2 Omicron BA.5

被引:0
|
作者
Zani, Alberto [1 ]
Messali, Serena [1 ]
Caccuri, Francesca [1 ]
机构
[1] Univ Brescia, Dept Mol & Translat Med, Sect Microbiol, Brescia, Italy
关键词
SARS-CoV-2; Omicron BA; 5; variant; disinfectants; Silver Barrier;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In this study we evaluated the antiviral activity of the Silver Barrier (R) disinfectant against SARS-CoV-2. Silver Barrier (R) showed time-and concentration-dependent antiviral activity against SARS-CoV-2. After 5 min contact time, Silver Barrier (R) at 0.002% showed a strong inhibitory effect (p < 0.001), with a 2-fold reduction of viral genome copy numbers, and a robust suppression (94%) of SARS-CoV-2 infectivity. Considering the effects obtained in solution and within a very short time, Silver Barrier (R) stands as an excellent new candidate for the disinfection of work environments, especially at the healthcare level, where there are people at high risk of serious illnesses.
引用
收藏
页码:60 / 64
页数:5
相关论文
共 50 条
  • [1] Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5
    Tuyji-Tok, Yesim
    Yucebag, Ebru
    Keles, Ayse Betul
    Kilincarslan, Ayse Ceylan
    Nohut, Okan Kadir
    Salman-Yilmaz, Seda
    Kuskucu, Mert Ahmet
    Midilli, Kenan
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2022, 4 (03): : 192 - 198
  • [2] Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
    Uraki, Ryuta
    Halfmann, Peter J.
    Iida, Shun
    Yamayoshi, Seiya
    Furusawa, Yuri
    Kiso, Maki
    Ito, Mutsumi
    Iwatsuki-Horimoto, Kiyoko
    Mine, Sohtaro
    Kuroda, Makoto
    Maemura, Tadashi
    Sakai-Tagawa, Yuko
    Ueki, Hiroshi
    Li, Rong
    Liu, Yanan
    Larson, Deanna
    Fukushi, Shuetsu
    Watanabe, Shinji
    Maeda, Ken
    Pekosz, Andrew
    Kandeil, Ahmed
    Webby, Richard J.
    Wang, Zhongde
    Imai, Masaki
    Suzuki, Tadaki
    Kawaoka, Yoshihiro
    NATURE, 2022, 612 (7940) : 540 - +
  • [3] First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco
    Colson, Philippe
    Lavagna, Christian
    Delerce, Jeremy
    Groshenry, Guillaume
    Yahi, Nouara
    Fantini, Jacques
    La Scola, Bernard
    Althaus, Thomas
    MICROORGANISMS, 2022, 10 (10)
  • [4] An ACE2-Based Decoy Inhibitor Effectively Neutralizes SARS-CoV-2 Omicron BA.5 Variant
    Zhang, Haoran
    Hu, Bing
    Lv, Panjing
    Liu, Yahui
    Guo, Meng
    Wu, Zhi
    Zhou, Kangping
    Dai, Minglu
    Yu, Xiao
    Liu, Zhang
    Yu, Bo
    Xu, Liqiong
    Guo, Min
    Cai, Kun
    Li, Yan
    VIRUSES-BASEL, 2022, 14 (11):
  • [5] The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5
    Shuai, Huiping
    Chan, Jasper Fuk-Woo
    Hu, Bingjie
    Chai, Yue
    Yoon, Chaemin
    Liu, Huan
    Liu, Yuanchen
    Shi, Jialu
    Zhu, Tianrenzheng
    Hu, Jing-Chu
    Hu, Ye-fan
    Hou, Yuxin
    Huang, Xiner
    Yuen, Terrence Tsz-Tai
    Wang, Yang
    Zhang, Jinjin
    Xia, Yao
    Chen, Lin-Lei
    Cai, Jian-Piao
    Zhang, Anna Jinxia
    Yuan, Shuofeng
    Zhou, Jie
    Zhang, Bao-Zhong
    Huang, Jian-Dong
    Yuen, Kwok-Yung
    To, Kelvin Kai-Wang
    Chu, Hin
    EBIOMEDICINE, 2023, 95
  • [6] Comparison of SARS-CoV-2 Viral Loads in the Nasal Mucosa of Patients Infected With BA.1, BA.2, or BA.5 Omicron Lineages
    Tozer, Kyla
    Sjaarda, Calvin P.
    Moslinger, Emily
    Wong, Henry
    Mubareka, Samira
    Maguire, Finlay
    Fattouh, Ramzi
    Brabant-Kirwan, Danielle
    Kozak, Robert
    Sheth, Prameet M.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (12):
  • [7] Virucidal Coatings Active Against SARS-CoV-2
    Barabanova, Anna I.
    Karamov, Eduard V.
    Larichev, Viktor F.
    Kornilaeva, Galina V.
    Fedyakina, Irina T.
    Turgiev, Ali S.
    Naumkin, Alexander V.
    Lokshin, Boris V.
    Shibaev, Andrey V.
    Potemkin, Igor I.
    Philippova, Olga E.
    MOLECULES, 2024, 29 (20):
  • [8] The Epidemiological Features of the SARS-CoV-2 Omicron Subvariant BA.5 and Its Evasion of the Neutralizing Activity of Vaccination and Prior Infection
    Tian, Dandan
    Nie, Wenjian
    Sun, Yanhong
    Ye, Qing
    VACCINES, 2022, 10 (10)
  • [9] Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2
    Chan, Jasper Fuk-Woo
    Hu, Bingjie
    Chai, Yue
    Shuai, Huiping
    Liu, Huan
    Shi, Jialu
    Liu, Yuanchen
    Yoon, Chaemin
    Zhang, Jinjin
    Hu, Jing-Chu
    Hou, Yuxin
    Huang, Xiner
    Yuen, Terrence Tsz-Tai
    Zhu, Tianrenzheng
    Li, Wenjun
    Cai, Jian-Piao
    Luo, Cuiting
    Yip, Cyril Chik-Yan
    Zhang, Anna Jinxia
    Zhou, Jie
    Yuan, Shuofeng
    Zhang, Bao-Zhong
    Huang, Jian-Dong
    Kai-Wang, Kelvin
    Yuen, Kwok-Yung
    Chu, Hin
    CELL REPORTS MEDICINE, 2022, 3 (09)
  • [10] Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
    Yamasoba, Daichi
    Kimura, Izumi
    Nasser, Hesham
    Morioka, Yuhei
    Nao, Naganor
    Ito, Jumpei
    Uriu, Keiya
    Tsuda, Masumi
    Zahradnik, Jiri
    Shirakawa, Kotaro
    Suzuki, Rigel
    Kishimoto, Mai
    Kosugi, Yusuke
    Kobiyama, Kouji
    Hara, Teppei
    Toyoda, Mako
    Tanaka, Yuri L.
    Butlertanaka, Erika P.
    Shimizu, Ryo
    Ito, Hayato
    Wang, Lei
    Oda, Yoshitaka
    Orba, Yasuko
    Sasaki, Michihito
    Nagata, Kayoko
    Yoshimatsu, Kumiko
    Asakura, Hiroyuki
    Nagashima, Mami
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Kuramochi, Jin
    Seki, Motoaki
    Fujiki, Ryoji
    Kaneda, Atsushi
    Shimada, Tadanaga
    Nakada, Taka-aki
    Sakao, Seiichiro
    Suzuki, Takuji
    Ueno, Takamasa
    Takaori-Kondo, Akifumi
    Ishii, Ken J.
    Schreiber, Gideon
    Sawa, Hirofumi
    Saito, Akatsuki
    Irie, Takashi
    Tanaka, Shinya
    Matsuno, Keita
    Fukuhara, Takasuke
    Ikeda, Terumasa
    Sato, Kei
    CELL, 2022, 185 (12) : 2103 - +